The Alliance for NanoHealth (ANH) was the first multi-disciplinary, multi-institutional collaborative research endeavor aimed solely at using nanotechnology to bridge the gaps between medicine, biology, materials science, computer technology and public policy. The mission of the Alliance is to collectively bridge the disciplines to develop nanotechnology-based solutions to unresolved problems in medicine. Its principal goal is to provide new clinical approaches to saving lives through better diagnosis, treatment, and prevention.

The ANH comprises eight world-class research institutions, scientists and clinicians located within the world’s largest collection of healthcare facilities, namely the Texas Medical Center and the greater Houston region. Member institutions include the Baylor College of Medicine, The University of Texas M.D. Anderson Cancer Center, Rice University, the University of Houston, The University of Texas Health Science Center at Houston, Texas A&M University, University of Texas Medical Branch and The Methodist Hospital Research Institute.

ANH institutions are committed to develop and apply nanotechnology tools in the battle against heart disease, cancer, diabetes, stroke, and infection. The willingness to share strengths among the disciplines with educational and training activities as well as welcoming new scientific associations provides a rich collaborative foundation upon which the ANH has established a wealth of research and development opportunities.